U.S. market Closed. Opens in 16 hours 55 minutes

VRPX | Virpax Pharmaceuticals, Inc. Stock Financials Income Statements Annual

(Stock Exchange: NASDAQ)
*Sign In to persist settings
Financial Year End2023-12-312022-12-312021-12-312020-12-312019-12-312018-12-31
RevenueN/AN/AN/AN/AN/AN/A
Cost of RevenueN/AN/AN/AN/AN/AN/A
Gross ProfitN/AN/AN/AN/AN/AN/A
Operating Expenses16.94M21.85M12.03M4.20M3.18M2.63M
Selling, General & Admin11.82M11.08M7.19M2.90M2.56M1.48M
Research & Development5.12M10.76M4.84M1.29M622.74K1.14M
Other Operating ExpensesN/A194.41K62.26K4.00KN/AN/A
Operating Income-16.94M-21.85M-12.03M-4.20M-3.18M-2.63M
Other Expenses / Income1.75M194.41K-30.56K-143.93K-124.64K-14.98K
Before Tax Income-15.19M-21.65M-12.06M-4.34M-3.31M-2.64M
Income Tax Expenses-12.94K-194.41K92.82K147.93K124.64KN/A
Net Income-15.19M-21.46M-12.15M-4.49M-3.43M-2.64M
Interest ExpensesN/A-194.41K92.82K147.93K124.64K14.98K
Basic Shares Outstanding1.17M1.17M1.17M494.51K521.51K4.95M
Diluted Shares Outstanding1.17M1.17M1.17M494.51K521.51K4.95M
EBITDA-16.94M-21.65M-11.96M-4.19M-3.18M-2.63M
EBITDA Margin0.00%0.00%0.00%0.00%0.00%0.00%
EBIT-15.20M-21.85M-11.96M-4.19M-3.18M-2.63M
EBIT Margin0.00%0.00%0.00%0.00%0.00%0.00%
Financial Year End2023-12-312022-12-312021-12-312020-12-312019-12-312018-12-31
An error has occurred. This application may no longer respond until reloaded. Reload 🗙